FDA Investigator CDR Jeremy L Wally, PhD
CDR Jeremy L Wally, PhD has inspections in 4 countries as of 23 Jun 2023. CDR Jeremy L Wally, PhD has collaborated with a combined 2062 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Belgium,
Canada
Co-Investigator(s):
Alla Kachko, PhD,
Anastasia I Offordile,
Anissa M Cheung,
Anita R Michael,
Ann L Demarco,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Arie C Menachem,
Audrey Thereset Uy,
Barbara M Frazier,
Brentley S Collins,
Brian S Keefer,
Burnell M Henry,
Cassandra Overking,
CDR Cecily Jones,
Chad R Burger,
Chao Ming Tsai,
Christian D Lynch (CDL),
Christina D Lynch,
Christina J Sauder, PhD,
Christina V Santos,
Christopher J Adams,
Cody D Rickman,
Craig D Zagata,
Cynthia Jim, CSO,
Dave Hafner,
David J Hafner,
Debra J Bennett,
Debra L Pagano,
Destry M Sillivan,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Ellen Huang,
Freddy Ortiz Colon,
Gene D Arcy,
Hala L Selby,
Haruhiko Murata,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
James M Mason,
Jean Lhu Primmer,
Joan A Loreng,
Joan Adamo,
Joanne M Hajoway,
Joseph George,
Julianne C Mccullough,
Junho Pak,
Karyn M Campbell,
Kathleen B Mihalik,
Kathryn Carbone, MD,
Kelly N Kerr,
Kenneth M Gordon,
Kristen D Evans,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Margaret E Digennaro,
Linda Thai,
Lisa Feela,
Lisa M Bellows,
LT John M Mastalski,
Marcellinus D Dordunoo,
Marian E Major, PhD,
Mark I Schwartz,
Martha T Olone,
Michael Curbag,
Michael Gurbarg,
Michael J Vardon,
Michele Perry Williams,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mizanne E Lewis,
Nawab A Siddiqui,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paul D Keller,
Paul W Keller,
Paula A Trost,
Peggy M Speight,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Ramon E Martinez,
Randa Melhem, PhD,
Rebecca K Olin,
Robert B Shibuya, MD,
Robert D Tollefsen,
Rose M Ashley,
Scott E Norris,
Scott T Ballard,
Sean R Bryd,
Seneca D Toms,
Shawn E Larson,
Sheila Dreher Lesnick,
Sherry G Bous,
Shuang Tang,
Simone E Pitts,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Steven A Rubin,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu,
Susant Hadman,
Tammy L Chavis,
Tina S Roecklein,
Uttaniti Limchumroon (Tom),
Vlada Matusovsky,
Wei Wang, PhD,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Xiaokuang Lai, PhD,
Yonggang Wang, PhD
CDR Jeremy L Wally, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2015 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2015-06-26 |
June, 2022 | FDA 483 | Seqirus Inc - Form 483, 2022-06-09 |
January, 2014 | FDA 483 | Merck Sharp & Dohme LLC - Form 483, 2014-01-17 |
April, 2021 | FDA 483 Response | Emergent Manufacturing Operations Baltimore LLC - Form 483R, 2021-04-30 |
June, 2022 | FDA 483 Response | Seqirus Inc - Form 483R, 2022-06-24 |
April, 2021 | FDA 483 | Emergent Manufacturing Operations Baltimore LLC - Form 483, 2021-04-20 |
June, 2022 | EIR | Seqirus Inc - EIR, 2022-06-09 |
April, 2021 | EIR | Emergent Manufacturing Operations Baltimore LLC - EIR, 2021-04-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more